Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-064681

Director acquired 12,485 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Coleman Mark Director 2026-02-20 Option exercise +12,485 $4.95 $61,801 65,890 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Coleman Mark Director 2026-02-20 Option exercise · Stock Option (Right to Buy) −12,485 13,971 D: show line 2 in the form
Loading xslF345X05/ownership.xml…